APR Applied Pharma Research s.a. (APR), as part of the Relief Group of companies, is a Swiss company dedicated to providing patients suffering from rare diseases with innovative treatments that make a real difference in their life.
Our focus, as a Swiss biopharma company is the identification, development and commercialization of best-in-class, patent protected products in selected rare and ultra-rare disease areas.
Our Services
Collaborations & Partnering
APR Applied Pharma Research
Has a proven track record in developing branded and patented products worldwide. |
Counts on a balanced mix of marketed, revenue-generating products and a compelling pipeline of innovative products in rare indications at different stages of development, with main focus on rare recessive metabolic diseases, rare dermatological diseases and ocular diseases. |
Offers late-stage licensing opportunities for internally developed products. |
Provides a complete and vertically integrated range of contract R&D services - from formulation to regulatory support on an international basis. |